by Editorial | Apr 29, 2020 | 2020 News, World Pharma Today
Genalyte’s U.S. Food and Drug Administration (FDA)-cleared Maverick™ Diagnostic System will expand antibody testing in the fight against COVID-19 with the launch of its SARS-CoV-2 Multi-Antigen Serology Panel. The antibody test and results represent a crucial step in...
by Editorial | Apr 29, 2020 | 2020 News, iMicroNews
First instrument-based, rapid test uses multi-antigen approach to achieve best-in-class sensitivity and specificity, U.S. FDA EUA submitted. Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, announced today...
Recent Comments